
Sign up to save your podcasts
Or


In Connecticut, residents are more likely to die from unintentional drug overdose than a motor vehicle accident, according to the state Department of Public Health.
Last year, more than 1,300 people died of accidental drug overdose – a 14.6% increase from 2019, and an 88.5% increase from 2015. Through January to June this year, 547 lives were lost to overdose, with additional deaths pending investigation.
This hour on Where We Live, we talk to a peer recovery specialist from Wheeler Clinic about her lived experience with childhood trauma, opioid use disorder, and medication assisted therapy. We discuss with experts the need for state funding for nonprofits offering substance use disorder treatment -- beyond the $60 million in additional dollars that will be allocated for adult and children’s mental health addiction services over the biennium -- at a time when patient demand is continuing to climb.
We also explore ways to invest the $300 million in settlements received by the state from Johnson & Johnson, Cardinal, McKesson, and AmerisourceBergen, and look into how opioid manufacturers and distributors are still pushing physician prescriptions in innovative ways, despite the Sunshine Act.
GUESTS:
Support the show: http://wnpr.org/donate
See omnystudio.com/listener for privacy information.
By Connecticut Public Radio4.2
5656 ratings
In Connecticut, residents are more likely to die from unintentional drug overdose than a motor vehicle accident, according to the state Department of Public Health.
Last year, more than 1,300 people died of accidental drug overdose – a 14.6% increase from 2019, and an 88.5% increase from 2015. Through January to June this year, 547 lives were lost to overdose, with additional deaths pending investigation.
This hour on Where We Live, we talk to a peer recovery specialist from Wheeler Clinic about her lived experience with childhood trauma, opioid use disorder, and medication assisted therapy. We discuss with experts the need for state funding for nonprofits offering substance use disorder treatment -- beyond the $60 million in additional dollars that will be allocated for adult and children’s mental health addiction services over the biennium -- at a time when patient demand is continuing to climb.
We also explore ways to invest the $300 million in settlements received by the state from Johnson & Johnson, Cardinal, McKesson, and AmerisourceBergen, and look into how opioid manufacturers and distributors are still pushing physician prescriptions in innovative ways, despite the Sunshine Act.
GUESTS:
Support the show: http://wnpr.org/donate
See omnystudio.com/listener for privacy information.

38,504 Listeners

25,828 Listeners

4,007 Listeners

57 Listeners

12,756 Listeners

4,672 Listeners

112,401 Listeners

56,702 Listeners

13 Listeners

3 Listeners

47 Listeners

4,784 Listeners

18 Listeners

6,423 Listeners

2 Listeners

0 Listeners

78 Listeners

29 Listeners

24 Listeners

16,010 Listeners

0 Listeners

317 Listeners

1,565 Listeners

11,492 Listeners

10 Listeners

21 Listeners

0 Listeners

0 Listeners

0 Listeners

0 Listeners

0 Listeners

44 Listeners

620 Listeners